Atrys Switzerland Cancer clinic in Liestal, Switzerland

Atrys is a global biomedical company based in Madrid, Spain. Providing precision diagnostics and cancer care, the company has a network of five specialist radiotherapy oncology centres in Switzerland, Spain and Portugal. Their Swiss centres are both located in the Basel region: Atrys Schweiz Liestal and Atrys Schweiz Allschwill.

Atrys’s oncology centres are all equipped with the most advanced radiotherapy treatments, including Image Guided Single Dose Radiation Therapy (IGRT) and hypofractionated radiotherapy. The treatments used aim to provide optimal results for patients, both in terms of efficacy in the fight against the disease and in the health and well-being of the patient during and after treatment. Use of the most up-to-date techniques and technologies reduces the chance of potential deleterious side effects and in many cases the treatment time is considerable shortened.

Other treatments available at Atrys’s clinics in Switzerland include medical oncology and second opinion consultations.

Treatment at Atrys is highly personalised and tailored to the individual’s needs. Teams in Switzerland join international colleagues on the Atrys Oncology Network committee each week to review every case and establish the best therapeutic option based on the latest medical-scientific advances, medical advice and best clinical practice.

Treatments provided

  • Radiotherapy

+ Add your organisation to IMTJ

Get full access to the most reliable numbers available on medical tourism

  • 192 country profiles: News, opinion, info and stats on in and outbound medical travel
  • FREE Enhanced Profile in the IMTJ Medical Travel Directory
  • Exclusive article archive: Full access to hundreds of articles providing insightful opinion and commentary from industry experts including Keith Pollard and Ian Youngman
  • 20% OFF selected reports
  • + much more

Organisation type



Atrys Schweiz Liestal
Radio Onkologie Liestal
Erzenbergstrasse 51
CH 4410

Contact details

Medical tourism news and opinion

  • Growing inbound medical travel: Qatar to Switzerland

    The Qatari Businessmen Association (QBA) has said it is in talks with Swiss companies and hospitals specialising in medical tourism and medical services, looking for investment opportunities to grow […]

  • USA stem cell treatments under FDA spotlight

    Unapproved stem cell therapies remain a top US Food and Drug Administration (FDA) enforcement priority in the USA. Recent court rulings in favour of the agency affirm that unproven stem cell therapy […]

  • Is wellness worth it?

    Adding wellness facilities adds more revenue, but comes with financial risks. Quantifying how big a difference wellness makes is difficult, but RLA Global has attempted to address the issue in its […]

Read more on LaingBuisson News